CM
RNAM

Capula Management’s Avidity Biosciences RNAM Stock Holding History

Capula Management’s Portfolio RNAM Stock Details RNAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-389,566
Closed -$28.1M – 1188
2025
Q4 		$28.1M Buy
+389,566
New +$25.2M 0.14% 71

Other funds holding RNAM

CC
Corsicana & Co Corsicana, Texas $158M AUM

Capula Management's RNAM Position: Q1 2026 in Review

Capula Management sold out of Avidity Biosciences (RNAM) in Q1 2026, closing a stake of 389,566 shares — an estimated $28.1M sold.

Capula Management first reported a position in RNAM in Q4 2025 and held it in 1 quarter. The position peaked at $28.1M in Q4 2025. 1 fund tracked by Wall St. Rank holds RNAM as of Q1 2026.

  • Capula Management reported no remaining Avidity Biosciences position as of Q1 2026 after selling out during the quarter.
  • Capula Management sold 389,566 Avidity Biosciences shares in Q1 2026, an estimated $28.1M.
  • Capula Management first reported a position in Avidity Biosciences in Q4 2025 and held it in 1 quarter.
  • Capula Management's Avidity Biosciences position peaked at $28.1M in Q4 2025.
  • 1 fund tracked by Wall St. Rank held Avidity Biosciences as of Q1 2026.

Based on Capula Management's 13F filing for Q1 2026, filed 14 May 2026.